Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.

Authors: Eeles, R.A. et al.

Journal: Nat Genet

Volume: 41

Issue: 10

Pages: 1116-1121

eISSN: 1546-1718

DOI: 10.1038/ng.450

Abstract:

Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To identify common PrCa susceptibility alleles, we previously conducted a genome-wide association study in which 541,129 SNPs were genotyped in 1,854 PrCa cases with clinically detected disease and in 1,894 controls. We have now extended the study to evaluate promising associations in a second stage in which we genotyped 43,671 SNPs in 3,650 PrCa cases and 3,940 controls and in a third stage involving an additional 16,229 cases and 14,821 controls from 21 studies. In addition to replicating previous associations, we identified seven new prostate cancer susceptibility loci on chromosomes 2, 4, 8, 11 and 22 (with P = 1.6 x 10(-8) to P = 2.7 x 10(-33)).

Source: PubMed

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

Authors: Eeles, R.A. et al.

Journal: NATURE GENETICS

Volume: 41

Issue: 10

Pages: 1116-1U97

eISSN: 1546-1718

ISSN: 1061-4036

DOI: 10.1038/ng.450

Source: Web of Science (Lite)

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.

Authors: Eeles, R.A. et al.

Journal: Nature genetics

Volume: 41

Issue: 10

Pages: 1116-1121

eISSN: 1546-1718

ISSN: 1061-4036

DOI: 10.1038/ng.450

Abstract:

Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To identify common PrCa susceptibility alleles, we previously conducted a genome-wide association study in which 541,129 SNPs were genotyped in 1,854 PrCa cases with clinically detected disease and in 1,894 controls. We have now extended the study to evaluate promising associations in a second stage in which we genotyped 43,671 SNPs in 3,650 PrCa cases and 3,940 controls and in a third stage involving an additional 16,229 cases and 14,821 controls from 21 studies. In addition to replicating previous associations, we identified seven new prostate cancer susceptibility loci on chromosomes 2, 4, 8, 11 and 22 (with P = 1.6 x 10(-8) to P = 2.7 x 10(-33)).

Source: Europe PubMed Central